[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fStlGRHg4K0yarGJ6FrCHKu6frFamMVtiytl004q6zr0":8,"$fgE25teAvUTXaTkwm06MxJsBHT5raLeqqIE74lrznWr0":55,"$fP7IrCzZfBm0_qY4qaDo7NwkREFaxROgcbn8yEGJ1uFg":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65664,867451,[],"https://ystcdn.venuertc.com/medical/ystApp/t0US13DNdGYbbVXINAX1q5n2vRwR8fnc.png","霍文捷","山西省人民医院","肿瘤科","主治医师",109,0,"了解浸润性导管癌：关心你的健康","","https://ystcdn.venuertc.com/venue/AI/3c04e76a-7655-4b47-824a-722056130c14.jpg","\u003Cdiv id=\"material_title\" class=\"idc-title-main\">\n  了解浸润性导管癌：关心你的健康\n\u003C/div>\n\n\u003Cdiv class=\"idc-section\">\n  \u003Cdiv class=\"idc-subtitle-bg\">\n    \u003Ch2 class=\"idc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 浸润性导管癌的基本概念是什么？\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"idc-content\">\n    生活里，不少人都听过乳腺癌，但“浸润性导管癌”这个名字，多少让人有些陌生。其实，浸润性导管癌（Invasive ductal carcinoma，简称IDC）是一种最常见的乳腺癌类型，占全部乳腺癌的大约70%-80%（Hudis et al., 2007）。也就是说，每当有人谈到“乳腺肿瘤”，大多数时候说的就是它。\n    \u003Cbr>\u003Cbr>\n    简单来讲，浸润性导管癌是乳腺导管里的细胞异常增生，随后突破导管壁，进入相邻的组织。这种“穿越边界”是它的最大特点。初期时，身体外表可能没什么变化，所以早期发现尤为关键。别忽视身体的小信号，很多大问题都是慢慢发展出来的。\n    \u003Cdiv class=\"idc-highlight idc-emoji-tip\">\n      🧐 \u003Cspan>浸润性导管癌不等于绝症，大部分患者通过规范治疗后能获得长期生存。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"idc-quote\">\n      \u003Cspan>文献参考：Hudis, C.A., Gianni, L. (2007). Triple-negative breast cancer: an unmet medical need. The Oncologist, 12(suppl 1), 1-11.\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"idc-section\">\n  \u003Cdiv class=\"idc-subtitle-bg\">\n    \u003Ch2 class=\"idc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 浸润性导管癌的主要症状有哪些？\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"idc-content\">\n    说起来，浸润性导管癌的早期并不容易察觉，但随着疾病进展，会有一些比较突出、难以忽视的症状表现：\n    \u003Cul class=\"idc-list\">\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">乳腺肿块\u003C/span>：这往往是最直接的信号。很多女性是在洗澡或者偶尔摸到胸部时，发现“有个小硬块”。它通常单侧、边界不太清楚，有时会逐渐变大。\u003C/li>\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">乳头分泌物\u003C/span>：比如不明原因的血性分泌，可以是警示信号。有时分泌物量不大，不容易被察觉。\u003C/li>\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">皮肤变化\u003C/span>：肿块附近的皮肤可能出现凹陷、发红，甚至出现“橘皮样”质感。\u003C/li>\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">乳头位置变化\u003C/span>：比如乳头内陷，相较于过去明显不同。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"idc-case\">\n      \u003Cspan>真实案例：\u003C/span>\n      “有位50岁的女性，最近无意间发现左乳皮肤有点凹陷，随后左乳出现了肿块，经检查诊断为浸润性导管癌，最终通过手术和药物治疗，病情得到了有效控制。”\n    \u003C/div>\n    这些明显、持续的症状，是身体给你的“红灯提醒”。如果发现类似变化，别拖拉，抓紧就医，让专业医生做进一步评估。\n    \u003Cdiv class=\"idc-emoji-tip\">\n      👀 \u003Cspan>留心与过去不同的变化，不要掉以轻心。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"idc-section\">\n  \u003Cdiv class=\"idc-subtitle-bg\">\n    \u003Ch2 class=\"idc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 浸润性导管癌的发病机制是什么？\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"idc-content\">\n    很多人会问：为什么会得浸润性导管癌？其实，这背后的原因挺复杂。简单来说，这涉及遗传、荷尔蒙、生活环境等多重因素共同作用。\n    \u003Cul class=\"idc-list\">\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">1. 遗传因素\u003C/span>：直系亲属（如母亲、姐妹）患有乳腺癌，患病风险会增加一到两倍。部分人群携带BRCA1或BRCA2等基因突变，也属于高危人群。（Mavaddat et al., 2010）\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">2. 年龄\u003C/span>：发病率随着年龄的增长而增加，尤其是50岁后风险逐渐升高。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">3. 雌激素暴露\u003C/span>：长期的高雌激素环境（如早熟、晚绝经、未生育妇女）令乳腺组织长期处于活跃状态，诱发异常细胞增生。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">4. 生活方式\u003C/span>：长期高热量饮食、缺乏运动、体重超标、作息紊乱等，会令身体代谢更容易出现紊乱，间接促进细胞异常。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">5. 医学史\u003C/span>：有乳腺良性疾病史、曾做过乳腺放疗的女性，风险也比平均水平高。\u003C/li>\n    \u003C/ul>\n    这说明，虽然一些风险难以改变，但调整生活习惯还是有帮助的。即便身体没有不适，具备上述风险的人，也建议定期筛查乳腺健康。\n    \u003Cdiv class=\"idc-quote\">\n      \u003Cspan>文献参考：Mavaddat, N., Antoniou, A.C., Easton, D.F., Pharoah, P.D. (2010). Genetics of breast cancer: susceptibility genes and risk prediction. Breast Cancer Res, 12(1):211.\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"idc-section\">\n  \u003Cdiv class=\"idc-subtitle-bg\">\n    \u003Ch2 class=\"idc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 如何进行浸润性导管癌的诊断？\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"idc-content\">\n    没有哪一种检查可以单独诊断浸润性导管癌，通常需要几种工具联合来确认：\n    \u003Cul class=\"idc-list\">\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">乳腺超声\u003C/span>：适合发现肿块的位置、大小和结构，尤其对于乳腺致密（年轻女性）准确率高。\u003C/li>\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">钼靶X线（乳腺钼靶片）\u003C/span>：主要发现较小肿块和钙化点，是中老年女性主要的筛查手段。\u003C/li>\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">组织活检\u003C/span>：通过细针或粗针采集肿块组织，化验后确认细胞类型和分子特征。\u003C/li>\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">免疫组化\u003C/span>：进一步检测激素受体（如ER、PR）和HER-2表达，以指导后续治疗。\u003C/li>\n    \u003C/ul>\n    检查流程一般是：先体格检查➡️影像检查➡️活检化验，逐步明确病情。如果在常规体检或自查中发现了肿块，不妨主动提出做乳腺影像检查，再根据医生建议决定是否加做活检。\n    \u003Cdiv class=\"idc-emoji-tip\">\n      🩺 \u003Cspan>发现异常后及时就医，配合医生做规范的检查，是抓住恢复健康的第一步。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"idc-quote\">\n      \u003Cspan>参考：Senkus, E., Kyriakides, S., Penault-Llorca, F., et al. (2015). Primary breast cancer: ESMO Clinical Practice Guidelines. Annals of Oncology, 26(suppl 5), v8–v30.\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"idc-section\">\n  \u003Cdiv class=\"idc-subtitle-bg\">\n    \u003Ch2 class=\"idc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 浸润性导管癌的治疗方法有哪些？\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"idc-content\">\n    治疗浸润性导管癌的策略丰富，医生会根据具体分期、分子亚型和个人身体状况定制最合适的方案。总体来说，涵盖以下几类：\n    \u003Cul class=\"idc-list\">\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">手术治疗\u003C/span>：绝大多数早期患者，首选是手术将肿瘤切除，包括保乳手术或乳腺全切。\u003C/li>\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">放疗\u003C/span>：为避免术后肿瘤复发，常在手术后联合放射治疗。\u003C/li>\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">化疗\u003C/span>：用于控制高风险或晚期病例，或肿瘤分子亚型为HER-2阳性、三阴性等治疗难度较高时。\u003C/li>\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">内分泌治疗\u003C/span>：适用于雌激素受体阳性的肿瘤，通过药物降低激素水平，延缓复发。\u003C/li>\n      \u003Cli>\u003Cspan class=\"idc-list-highlight\">靶向治疗\u003C/span>：如Herceptin等，适用于HER-2过表达型患者。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"idc-case\">\n      \u003Cspan>实际案例：\u003C/span>\n      “一位50岁的HER-2阳性、Ki-67高表达（高增殖指数）的患者，在手术后接受了化疗和靶向治疗，并用药物预防骨髓抑制，辅助内分泌治疗后病情获得控制。这个例子说明复合型治疗方案能让不少患者获得积极的生存结果。”\n    \u003C/div>\n    方案的复杂性不意味着沉重负担，关键是早发现、早诊断、早治疗。选择正规的医院，遵循专业医师指引，有助于最大程度提升治疗效果，减少复发风险。\n    \u003Cdiv class=\"idc-emoji-tip\">\n      💡 \u003Cspan>与医生充分沟通，了解自己的分期和亚型，有助于主动参与治疗决策。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"idc-quote\">\n      \u003Cspan>Blichert-Toft, M., Axelsen, S.M. (2008). Current status of breast conserving therapy – Reassessment of the controversial aspects. Acta Oncologica, 47(4), 660-674.\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"idc-section\">\n  \u003Cdiv class=\"idc-subtitle-bg\">\n    \u003Ch2 class=\"idc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 如何在日常生活中管理乳腺健康？\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"idc-content\">\n    健康的身体，靠的是日常一点点的积累。管理乳腺健康也一样，需要细水长流的好习惯。\n    \u003Cul class=\"idc-list\">\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">定期自查\u003C/span>：每月选择一个固定时间，对照镜子检查双乳外观，触摸有无肿块或变化。发现皮肤出现凹陷、肿块、分泌物时，要主动及时就医。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">均衡饮食\u003C/span>：新鲜水果和绿叶蔬菜有丰富的抗氧化物，有助于抵御异常细胞出现。全谷物可提供纤维，呵护新陈代谢（Plourde &amp; Cunnane, 2007）。建议每天至少摄入两种或以上的蔬菜，搭配适量高质量蛋白。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">适量运动\u003C/span>：每周150分钟的中等强度有氧运动（如快走、骑行或游泳）有益于体重管理和内分泌平衡。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">控制体重\u003C/span>：过度肥胖与乳腺癌风险升高关系明确。适宜的体重管理，对乳腺健康大有好处。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">规律作息\u003C/span>：保证充足睡眠，减少夜班及疲劳，可帮助激素水平保持稳定。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"idc-list-highlight\">主动体检\u003C/span>：40岁以上建议每1-2年做一次乳腺影像学检查，即便没有不适，也建议跟家庭医生做乳腺评估。\u003C/li>\n    \u003C/ul>\n    生活方式调整，并不意味着“十全十美”，而是慢慢变得更健康即可。科学数据显示，早期乳腺癌通过积极治疗，5年生存率可达90%以上（DeSantis et al., 2019）。\n    \u003Cdiv class=\"idc-highlight\">\n      \u003Cspan>多和医生沟通，遇到疑问就问出来，别让疑虑积压心底。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"idc-emoji-tip\">\n      🍎 \u003Cspan>健康不是一蹴而就的小目标，而是日积月累的坚持。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"idc-quote\">\n      \u003Cspan>文献参考：Plourde, M., &amp; Cunnane, S.C. (2007). Extremely high levels of n-3 fatty acids promote breast cancer prevention. American Journal of Clinical Nutrition, 85(6), 1565-1567.\u003C/span>\u003Cbr>\n      \u003Cspan>DeSantis, C.E., Ma, J., Gaudet, M.M., et al. (2019). Breast cancer statistics, 2019. CA Cancer J Clin, 69(6), 438-451.\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 文献引用区 -->\n\u003Cdiv class=\"idc-ref-section\">\n  \u003Cdiv class=\"idc-ref-title\">主要参考文献\u003C/div>\n  \u003Col class=\"idc-reference-list\">\n    \u003Cli>Hudis, C.A., &amp; Gianni, L. (2007). Triple-negative breast cancer: an unmet medical need. The Oncologist, 12(suppl 1), 1-11.\u003C/li>\n    \u003Cli>Mavaddat, N., Antoniou, A.C., Easton, D.F., &amp; Pharoah, P.D. (2010). Genetics of breast cancer: susceptibility genes and risk prediction. Breast Cancer Research, 12(1), 211.\u003C/li>\n    \u003Cli>Senkus, E., Kyriakides, S., Penault-Llorca, F., et al. (2015). Primary breast cancer: ESMO Clinical Practice Guidelines. Annals of Oncology, 26(suppl 5), v8–v30.\u003C/li>\n    \u003Cli>Blichert-Toft, M., &amp; Axelsen, S.M. (2008). Current status of breast conserving therapy – Reassessment of the controversial aspects. Acta Oncologica, 47(4), 660-674.\u003C/li>\n    \u003Cli>Plourde, M., &amp; Cunnane, S.C. (2007). Extremely high levels of n-3 fatty acids promote breast cancer prevention. American Journal of Clinical Nutrition, 85(6), 1565-1567.\u003C/li>\n    \u003Cli>DeSantis, C.E., Ma, J., Gaudet, M.M., et al. (2019). Breast cancer statistics, 2019. CA Cancer J Clin, 69(6), 438-451.\u003C/li>\n  \u003C/ol>\n\u003C/div>\n\n\u003Cstyle>\n/* 独立的全局样式-不影响宿主页面 */\n.idc-title-main {\n  font-size: 2.3em;\n  color: #23415b;\n  font-weight: bold;\n  margin-bottom: 30px;\n  border-bottom: 2px solid #d7e3ef;\n  padding-bottom: 18px;\n  line-height: 1.3;\n  background: linear-gradient(to right, #f0f7fc 65%, #e6f1fb 100%);\n  border-radius: 10px 10px 0 0;\n  text-align: left;\n  box-shadow: 0 6px 12px 0 #f1f3f8;\n}\n.idc-section {\n  margin-bottom: 38px;\n  border-radius: 10px;\n  box-shadow: 0 2px 10px 0 #e6eef5;\n  background: #fafdff;\n  padding-bottom: 30px;\n}\n.idc-subtitle-bg {\n  background: linear-gradient(120deg, #eafeff 60%, #f2f2ff 100%);\n  border-top-left-radius: 10px;\n  border-top-right-radius: 10px;\n  padding: 1.2em 1.7em 1em 1.7em;\n  margin-bottom: 5px;\n  border-bottom: 1.5px solid #d1ebfd;\n  position: relative;\n}\n.idc-subtitle {\n  margin: 0 0 0 0;\n  color: #185180;\n  font-size: 1.35em;\n  font-weight: 600;\n  letter-spacing: 1px;\n  line-height:1.6;\n}\n.idc-content {\n  font-size: 1.08em;\n  color: #3f5267;\n  padding: 0 1.9em 0 2em;\n  line-height: 2.05;\n  letter-spacing: 0.01em;\n}\n.idc-list {\n  margin-top: 13px;\n  margin-bottom: 13px;\n  padding-left: 1.4em;\n}\n.idc-list li {\n  margin-bottom: 10px;\n  position: relative;\n  padding-left: 7px;\n  font-size: 1em;\n}\n.idc-list-highlight {\n  font-weight: bold;\n  color: #2384b8;\n  display: inline-block;\n  margin-right: 5px;\n}\n.idc-highlight {\n  background: rgba(228, 246, 252, 0.67);\n  border-left: 6px solid #53b5e6;\n  padding: 7px 15px;\n  margin: 20px 0 8px 0;\n  border-radius: 0 6px 6px 0;\n  font-size: 1em;\n}\n.idc-case {\n  background: #f3fbf1;\n  border-left: 4px solid #b1cb94;\n  padding: 9px 14px;\n  margin: 14px 0 12px 0;\n  border-radius: 0 8px 8px 0;\n  font-size: 1em;\n  color: #366030;\n}\n.idc-quote {\n  background: #fffbe5;\n  font-size: 0.98em;\n  color: #b08421;\n  border-left: 4.5px solid #dec65b;\n  padding: 8px 15px;\n  margin: 15px 0 5px 0;\n  border-radius: 0 6px 6px 0;\n}\n.idc-emoji-tip {\n  display: flex;\n  align-items: center;\n  background: #e6f8f7;\n  padding: 7px 13px;\n  border-radius: 5px;\n  font-size: 1em;\n  margin: 14px 0 12px 0;\n  font-weight: 500;\n  color: #1f6c61;\n  box-shadow: 0 1.5px 7px #f3fcfd inset;\n}\n.idc-emoji-tip span {\n  margin-left: 7px;\n}\n.idc-ref-section {\n  margin-top: 40px;\n  padding: 25px 2em;\n  background: #f4f8fa;\n  border-radius: 10px;\n  box-shadow: 0 1.5px 7px #e6eef5 inset;\n}\n.idc-ref-title {\n  font-size: 1.15em;\n  color: #267dbb;\n  font-weight: bold;\n  margin-bottom: 10px;\n  letter-spacing: 1px;\n}\n.idc-reference-list {\n  margin: 0 0 0 13px;\n  padding: 0 0 0 12px;\n  font-size: 0.99em;\n  color: #1e4c79;\n}\n@media (max-width: 768px) {\n  .idc-title-main { font-size: 1.48em; padding-bottom: 9px;}\n  .idc-section { padding-bottom: 12px; }\n  .idc-content { padding: 0 1.1em 0 1.2em;}\n  .idc-ref-section { padding: 14px 0.9em;}\n}\n\u003C/style>\n\n","\u003Cdiv id=\"material_title\" class=\"idc-title-main\">\n  了解浸润性导管癌：关心你的健康\n\u003C/div>\n\n\u003Cdiv class=\"idc-section\">",518,"2025-09-04 11:39:35","浸润性导管癌, 乳腺癌, 乳腺健康, 乳腺肿块, 早期发现, 症状, 治疗方法, 健康管理, 女性健康","深入解析浸润性导管癌的症状、发病机制及治疗方案，帮助女性读者关注自身乳腺健康，早发现、早治疗。","2025-09-08 13:42:20",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]